Molecular Partners to present MP0712 at two 2026 cancer conferences
AI Summary- Molecular Partners will present MP0712 at two 2026 scientific conferences.
- MP0712 targets DLL3 and uses 212Pb in a Phase 1/2a study.
- The conferences take place November 4–7 and December 4–6, 2026.